BioTuesdays Feature Articles | Life Sciences News

Feature

Dr. Doug Manion of Kleo Pharmaceuticals talks up new approach to treating multiple myeloma

As chairman and CEO of Kleo Pharmaceuticals, a private immuno-oncology company developing next-generation bispecific compounds designed to enhance the activity of biologics, Dr. Doug Manion has a distinguished pedigree...

April 7, 2020

Feature

Amidst a global pandemic, two biotech companies offer innovative solutions

Since COVID-19 was first identified in China late last year, researchers have been working tirelessly to develop diagnostics, therapeutics and vaccines in an effort to prevent the spread of the SARS-CoV-2 virus. Many...

March 31, 2020

Feature

Bee Vectoring bringing nature’s solution to healthy crops

Using the natural pollination process of commercially-reared bees and biological products and controls, Bee Vectoring Technology International (TSXV, CVE:BEE; OTCQB:BEVVF) has developed a pest and disease solution for...

March 24, 2020

Feature

Obalon developing retail strategy for its weight loss solution: a swallowable, gas-filled intragastric balloon

Obalon Therapeutics (NASDAQ:OBLN) is pivoting its business model to a retail strategy of company-managed clinics to deliver its Obalon Balloon System, a weight loss solution that is the first and only swallowable, gas...

March 17, 2020

Feature

Diabeloop bringing innovation to Type 1 diabetes patients

Closely-held Diabeloop of Grenoble, France has developed an external Type 1 diabetes management system, known as DBLG1, that connects three components: a continuous glucose monitor, a patch-like insulin pump and an...

March 10, 2020

Feature

Anixa Biosciences harnessing interactions between tumors and the immune system

Anixa Biosciences (NASDAQ:ANIX) is taking multiple approaches to fighting cancer, developing both a diagnostic and therapeutics, such as a cancer immunotherapy and vaccine, to overcome immuno-suppression. Anixa...

March 3, 2020

Feature

Ocugen developing therapies for rare and underserved eye diseases

Ocugen (NASDAQ:OCGN) is taking a multi-pronged approach to ophthalmology with a diversified pipeline that includes a breakthrough modifier gene therapy platform, novel biologics and small molecules, targeting a broad...

February 25, 2020

Feature

Genocea Biosciences: for the next generation of immunotherapies, targets matter

Using its unique ATLAS proprietary technology platform, Genocea Biosciences (NASDAQ:GNCA) is developing cancer immunotherapies that direct the body’s own tumor-fighting T-cells to the most therapeutically relevant...

February 18, 2020

Feature

Ripple Therapeutics pursues financing for Phase 2 intravitreal implant trial and Epidel platform expansion

Closely-held Ripple Therapeutics, a recent spinout from Interface Biologics, is pursuing a $25-million series A financing to complete a Phase 2 trial of IBE-814 IVT, a dexamethasone prodrug intravitreal implant, and...

February 11, 2020

Feature

Stereotaxis focused on next generation robotic innovation in interventional medicine

Stereotaxis’ (NYSE American: STXS) launch in June 2019 of a next generation surgical robotic system, Genesis RMN, solidifies its commitment to innovation and collaboration as a stepping stone to improve patient care...

February 4, 2020

Feature

Inagene personalizing pain management with comprehensive genetic test

Closely-held pharmacogenetics company, Inagene Diagnostics, aims to replace the “trial-and-error” approach to pain management with a comprehensive genetic test that helps physicians provide personalized pain management...

January 28, 2020

Feature

Liminal BioSciences making headway in strategic transformation

Liminal BioSciences (NASDAQ, TSX:LMNL) is undergoing a significant strategic transformation to simplify its operations, achieve financial stability and focus R&D on small molecule therapeutics. “This is a refresh of...

January 21, 2020

Feature

iBio’s transformation driven by FastPharming System, 3D bioprinting materials and proprietary therapeutics

iBio (NYSE American:IBIO) is continuing its transition from a licensing business to a manufacturing services provider and developer of proprietary biologics. Central to the initiative is a new brand for its core...

January 14, 2020

Feature

BriaCell breast cancer program ready for partnering

BriaCell Therapeutics (OTCQB:BCTXD; TSXV:BCT) believes its Phase 2 clinical program in advanced breast cancer, which includes an ongoing combination study of its Bria-IMT with immune checkpoint inhibitors such as...

January 7, 2020

Feature

Clene Nanomedicine developing first nanotherapeutic for neurodegenerative disease

Closely-held Clene Nanomedicine is developing catalytic drugs to treat neurodegenerative diseases, using its clean surface nanocrystal (CSN) therapeutics platform to increase cellular bioenergy. “We’re the first...

December 17, 2019

Feature

Kane Biotech completes 12-month transformation; ready for robust growth

Kane Biotech (TSXV:KNE) has completed a major transformation during the past year, relaunching its animal health business, expanding into human health, raising non-dilutive financing, and hiring a new executive team...

December 10, 2019

Feature

Squarex hopes to begin pivotal testing to prevent recurring cold sores in 2020

Closely-held Squarex will be seeking an end-of-Phase 2 meeting with the FDA in the first quarter of 2020 as a steppingstone for pivotal testing of its SQX770 topical treatment for the prevention of recurrent cold sores...

December 3, 2019

Feature

Artelo readies Phase 1b/2a trial of cannabinoid agonist for cancer-related anorexia

Artelo Biosciences (NASDAQ:ARTL) is gearing up to begin a UK-based Phase 1b/2a study of its cannabinoid agonist drug candidate, ART 27.13, which has the potential to stimulate cancer patients’ appetite and promote...

November 26, 2019

Feature

Ventripoint readies sales push of 3D heart imaging VMS+ 3.0 device

With FDA approval in October of its VMS+ 3.0 system, which turns 2D echocardiograms into MRI equivalent 3D images, Ventripoint Diagnostics (TSXV:VPT, OTCQB:VPTDF) is gearing up for a major sales and marketing program in...

November 19, 2019

Feature

Spring Bank heading into data-rich 2020

Spring Bank Pharmaceuticals (NASDAQ:SBPH) will be reporting clinical data readouts throughout 2020 as it advances a portfolio of three drug candidates for the treatment of chronic hepatitis B virus (HBV) as well as...

November 12, 2019

Feature

Lobo Genetics enabling personalized cannabis product selection based on consumers’ genes

Closely-held Lobo Genetics is taking its cannabis genetic profile testing to the next level. “We started with genetic tests and genetic profiling and now we are complementing that by helping guide consumers to the right...

November 5, 2019

Feature

Soricimed’s platform of unique peptides making waves in cancer and beyond

Closely-held Soricimed Biopharma has developed a first-in-class platform of synthetic peptides whose various targets include an “oncochannel” implicated in the development and progression of many forms of cancer.

October 29, 2019

Dr. Doug Manion of Kleo Pharmaceuticals talks up new approach to treating multiple myeloma

Amidst a global pandemic, two biotech companies offer innovative solutions

Bee Vectoring bringing nature’s solution to healthy crops

Obalon developing retail strategy for its weight loss solution: a swallowable, gas-filled intragastric balloon

Diabeloop bringing innovation to Type 1 diabetes patients

Anixa Biosciences harnessing interactions between tumors and the immune system

Ocugen developing therapies for rare and underserved eye diseases

Genocea Biosciences: for the next generation of immunotherapies, targets matter

Ripple Therapeutics pursues financing for Phase 2 intravitreal implant trial and Epidel platform expansion

Stereotaxis focused on next generation robotic innovation in interventional medicine

Inagene personalizing pain management with comprehensive genetic test

Liminal BioSciences making headway in strategic transformation

iBio’s transformation driven by FastPharming System, 3D bioprinting materials and proprietary therapeutics

BriaCell breast cancer program ready for partnering

Clene Nanomedicine developing first nanotherapeutic for neurodegenerative disease

Kane Biotech completes 12-month transformation; ready for robust growth

Squarex hopes to begin pivotal testing to prevent recurring cold sores in 2020

Artelo readies Phase 1b/2a trial of cannabinoid agonist for cancer-related anorexia

Ventripoint readies sales push of 3D heart imaging VMS+ 3.0 device

Spring Bank heading into data-rich 2020

Lobo Genetics enabling personalized cannabis product selection based on consumers’ genes

Soricimed’s platform of unique peptides making waves in cancer and beyond

General

More